SUPPLEMENT

Q2 2022 — Income statement trends

Q2 2022PDF · 2 pages144 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q220 	Q320 	Q420 	Q121 	Q221 	Q321 	Q421 	Q122 	Q222
Revenues:
Clearing and transaction fees 	940.2 	835.4 	843.0 	1,007.0 	929.9 	878.9 	949.3 	1,138.1 	1,024.6
Market data and information services 	134.7 	139.4 	139.8 	144.2 	145.2 	145.4 	142.1 	151.7 	151.7
Other Revenue 	107.4 	105.9 	115.7 	102.1 	104.1 	85.6 	55.9 	56.8 	60.9
Total revenues 	1,182.3 	1,080.7 	1,098.5 	1,253.3 	1,179.2 	1,109.9 	1,147.3 	1,346.6 	1,237.2
Expenses:
Compensation and benefits 	217.0 	216.4 	215.6 	225.0 	211.7 	198.6 	201.7 	185.2 	185.3
Technology 	49.1 	48.1 	53.6 	48.2 	49.3 	49.3 	45.8 	45.9 	45.9
Professional fees and outside services 	51.2 	48.4 	50.0 	37.4 	36.8 	45.2 	32.3 	31.8 	32.0
Amortization of purchased intangibles 	76.6 	78.3 	79.0 	60.6 	59.4 	59.0 	58.6 	58.4 	57.1
Depreciation and amortization 	36.7 	39.7 	41.5 	37.6 	37.1 	37.2 	35.9 	33.5 	33.0
Licensing and other fee agreements 	55.4 	57.7 	57.9 	64.7 	54.2 	57.6 	60.4 	80.9 	83.1
Other expense 	58.8 	67.1 	85.9 	54.7 	56.0 	49.3 	80.9 	51.8 	51.1
Operating expenses 	544.8 	555.7 	583.5 	528.2 	504.5 	496.2 	515.6 	487.5 	487.5
Operating Income 	637.5 	525.0 	515.0 	725.1 	674.7 	613.7 	631.7 	859.1 	749.7
Operating Margin 	54% 	49% 	47% 	58% 	57% 	55% 	55% 	64% 	61%
Non-operating Income and Expense
Investment income 	32.1 	23.6 	31.1 	30.9 	62.4 	145.8 	67.8 	73.1 	286.9
Interest and other borrowing costs 	(41.9) 	(41.7) 	(41.7) 	(41.5) 	(41.7) 	(41.8) 	(41.9) 	(42.5) 	(39.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	48.8 	44.0 	46.6 	56.2 	55.7 	66.4 	67.5 	73.3 	87.3
Other non-operating income (expense) 	(15.2) 	(14.4) 	(16.0) 	(18.4) 	(25.0) 	311.8 	74.2 	(46.7) 	(217.3)
Non-operating income (expense) 	23.8 	11.5 	20.0 	27.2 	51.4 	482.2 	167.6 	57.2 	117.0
Income before income taxes 	661.3 	536.5 	535.0 	752.3 	726.1 	1,095.9 	799.3 	916.3 	866.7
Income taxes 	158.0 	125.0 	110.2 	177.5 	215.5 	169.6 	174.1 	205.3 	204.2
Net income 	503.3 	411.5 	424.8 	574.8 	510.6 	926.3 	625.2 	711.0 	662.5
Less: net income (loss) attributable to NCI 	- 	(0.2) 	0.8 	0.4 	0.3 	(0.2) 	- 	- 	-
Net Income Attributable to CME Group 	503.3 	411.7 	424.0 	574.4 	510.3 	926.5 	625.2 	711.0 	662.5
Net Income Attributable to CME Group 	503.3 	411.7 	424.0 	574.4 	510.3 	926.5 	613.3 	702.0 	654.1
Effective Tax Rate 	23.9% 	23.3% 	20.6% 	23.6% 	29.7% 	15.5% 	21.8% 	22.4% 	23.6%
Earnings per Share:
Basic EPS 	1.41 	1.15 	1.18 	1.60 	1.42 	2.59 	1.71 	1.96 	1.82
Diluted EPS 	1.40 	1.15 	1.18 	1.60 	1.42 	2.58 	1.71 	1.95 	1.82
Weighted average number of common stock shares:
Basic Shares 	357,691 	357,791 	358,047 	358,147 	358,261 	358,363 	358,582 	358,609 	358,641
Diluted Shares 	358,457 	358,590 	358,612 	358,817 	358,888 	358,988 	359,019 	359,180 	359,205
Preferred Shares 	2,890 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q220 	Q320 	Q420 	Q121 	Q221 	Q321 	Q421 	Q122 	Q222
Revenues:
Clearing and transaction fees 	940.2 	835.4 	843.0 	1,007.0 	929.9 	878.9 	949.3 	1,138.1 	1,024.6
Market data and information services 	134.7 	139.4 	139.8 	144.2 	145.2 	145.4 	142.1 	151.7 	151.7
Other Revenue 	107.4 	105.9 	115.7 	102.1 	101.0 	85.6 	55.9 	56.8 	60.9
Total revenues 	1,182.3 	1,080.7 	1,098.5 	1,253.3 	1,176.1 	1,109.9 	1,147.3 	1,346.6 	1,237.2
Expenses:
Compensation and benefits 	202.7 	205.5 	202.6 	207.5 	201.9 	191.1 	183.7 	182.8 	189.5
Technology 	48.5 	47.3 	52.2 	47.7 	49.2 	49.1 	45.6 	45.8 	45.9
Professional fees and outside services 	42.7 	40.0 	39.2 	27.9 	30.0 	26.5 	27.2 	30.3 	31.4
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	33.7 	37.0 	37.2 	36.8 	36.7 	36.7 	35.6 	33.5 	32.9
Licensing and other fee agreements 	55.4 	57.7 	57.9 	64.7 	54.2 	57.6 	60.4 	80.9 	83.1
Other expense 	51.9 	56.1 	74.3 	52.1 	54.8 	51.3 	76.5 	51.7 	59.6
Operating expenses 	434.9 	443.6 	463.4 	436.7 	426.8 	412.3 	429.0 	425.0 	442.4
Operating Income 	747.4 	637.1 	635.1 	816.6 	749.3 	697.6 	718.3 	921.6 	794.8
Operating Margin 	63% 	59% 	58% 	65% 	64% 	63% 	63% 	68% 	64%
Non-operating Income and Expense
Investment income 	26.4 	22.6 	24.1 	26.9 	37.3 	55.1 	58.2 	74.7 	299.5
Interest and other borrowing costs 	(41.9) 	(41.7) 	(41.7) 	(41.5) 	(41.7) 	(41.8) 	(41.9) 	(42.5) 	(39.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	48.8 	44.0 	46.6 	56.2 	55.7 	70.5 	78.7 	84.7 	98.2
Other non-operating income (expense) 	(15.2) 	(14.4) 	(16.0) 	(18.4) 	(25.0) 	(32.9) 	(33.0) 	(43.4) 	(218.5)
Non-operating income (expense) 	18.1 	10.5 	13.0 	23.2 	26.3 	50.9 	62.0 	73.5 	139.3
Income before income taxes 	765.5 	647.6 	648.1 	839.8 	775.6 	748.5 	780.3 	995.1 	934.1
Income taxes 	182.3 	152.8 	150.2 	198.2 	186.7 	174.3 	172.8 	228.9 	217.6
Net income 	583.2 	494.8 	497.9 	641.6 	588.9 	574.2 	607.5 	766.2 	716.5
Less: net income (loss) attributable to NCI 	- 	(0.2) 	0.8 	0.4 	0.3 	(0.2) 	- 	- 	-
Net Income Attributable to CME Group 	583.2 	495.0 	497.1 	641.2 	588.6 	574.4 	607.5 	766.2 	716.5
Net Income Attributable to Common Shareholders of CME Group 	583.2 	495.0 	497.1 	641.2 	588.6 	574.4 	595.7 	756.6 	707.5
Effective Tax Rate 	23.8% 	23.6% 	23.2% 	23.6% 	24.1% 	23.3% 	22.1% 	23.0% 	23.3%
Earnings per Share:
Basic EPS 	1.63 	1.38 	1.39 	1.79 	1.64 	1.60 	1.66 	2.11 	1.97
Diluted EPS 	1.63 	1.38 	1.39 	1.79 	1.64 	1.60 	1.66 	2.11 	1.97
Weighted average number of common stock shares:
Basic Shares 	357,691 	357,791 	358,047 	358,147 	358,261 	358,363 	358,582 	358,609 	358,641
Diluted Shares 	358,457 	358,590 	358,612 	358,817 	358,888 	358,988 	359,019 	359,180 	359,205
Preferred Shares 	- 	- 	- 	- 	- 	- 	2,890 	4,584 	4,584

-- 2 of 2 --